Salesforce: H2 FY2026 Guidance Looks Conservative, Leaving Room For Upside

Salesforce surpassed 2Q FY2026 revenue and EPS estimates, but its forward guidance, largely aligning with consensus, triggered a post-earnings stock pullback. The company's outlook projects flat year-over-year growth in cRPO and operating margin, with no near-term rebound in total revenue, despite strong AI-related revenue growth which still constitutes a small portion of overall sales. While 4Q FY2026 EPS growth is expected to slow to single digits, Salesforce continues to generate strong free cash flow, and its current valuation of 21.5x non-GAAP P/E forward positions it as a long-term play without immediate inflection.

Analysis

Salesforce reported a beat on both revenue and EPS for Q2 FY2026, yet its stock experienced a pullback due to forward guidance that was merely in-line with consensus expectations. The company's outlook suggests a period of stabilization rather than re-acceleration, with projections implying flat year-over-year growth for both current Remaining Performance Obligation (cRPO) and operating margin. While revenue from AI initiatives is growing strongly, it represents a minor portion of the total and is not expected to materially contribute to top-line growth for several quarters. Further tempering expectations, 4Q FY2026 EPS growth is forecast to slow to single digits. Despite the lackluster growth outlook, the company continues to generate robust free cash flow. The stock's valuation at 21.5x forward non-GAAP P/E is presented as a potential bargain for a leading enterprise software firm, but it also signals that the market does not anticipate any significant near-term inflection points.

Key Decisions for Investors

• Investors with a long-term horizon may view the post-earnings pullback as a strategic entry point, given the strong free cash flow and a valuation of 21.5x forward P/E, but should not expect significant near-term appreciation.
• Traders and investors focused on short-term momentum should exercise caution, as the guidance for flat cRPO growth and slowing EPS signals a potential period of stock underperformance until a clear growth catalyst materializes.
• Closely monitor the revenue contribution from AI products in subsequent quarters, as a meaningful increase in its share of total revenue will be the primary indicator for a potential growth re-acceleration and a positive re-rating of the stock.